Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-09-05
REV
Q1 2021Est.ActualSurprise
EPS-1.300
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TALSTalaris Therapeutics0%

Talaris Therapeutics Frequently Asked Questions

Q

How do I buy Talaris Therapeutics (TALS) stock?

A

You can purchase shares of Talaris Therapeutics (NASDAQ: TALS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Talaris Therapeutics's (TALS) competitors?

A

There are no as such competitors for Talaris Therapeutics.

Q

What is the target price for Talaris Therapeutics (TALS) stock?

A

The latest price target for Talaris Therapeutics (NASDAQ: TALS) was reported by Morgan Stanley on June 1, 2021. The analyst firm set a price target for 35.00 expecting TALS to rise to within 12 months (a possible 106.49% upside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Talaris Therapeutics (TALS)?

A

The stock price for Talaris Therapeutics (NASDAQ: TALS) is $16.95 last updated Fri Jun 18 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Q

Does Talaris Therapeutics (TALS) pay a dividend?

A

There are no upcoming dividends for Talaris Therapeutics.

Q

When is Talaris Therapeutics (NASDAQ:TALS) reporting earnings?

A
Talaris Therapeutics’s Q2 earnings are confirmed for after-market on September 5, 2021.
Q

Is Talaris Therapeutics (TALS) going to split?

A

There is no upcoming split for Talaris Therapeutics.

Q

What sector and industry does Talaris Therapeutics (TALS) operate in?

A

Talaris Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.